|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes : the LEAD ( liraglutide effect and ac- tion in diabetes) -2 study显示文摘 | Nauck M Ellis GC Fleck PR | 2009 | Diabetes Care2009，32，1： | 1 |
| 2 | Antiangiogenic therapyevolving view based on clinical trial results显示文摘 | Jayson GC Hicklin DJ Ellis LM | | 0，，05： | 1 |
| 3 | Antiangiogenic therapyevolving view based on clinical trial results显示文摘 | Jayson GC Hicklin DJ Ellis LM | | 0，，05： | 1 |
| 4 | Diagnosis- based risk adjustment for Medicare capitation payments显示文摘 | Ellis RP Pope GC Iezzoni LI Ayanian JZ | 1996 | Health Care Financing Review1996，12，3： | 1 |
| 5 | A clinical grading scale to predict malignant hyperthermia susceptibility 显示文摘 | Larach MG Localio AR Allen GC Denborough MA Ellis FR Gronert GA | 1994 | Anesthesiology1994，80，4： | 1 |
| 6 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy : a multicentre, randomised, double-blind, placebo-controlled study 显示文摘 | Nauck MA Ellis GC Fleck PR | 2009 | Int J Clin Pract2009，63，1： | 1 |
| 7 | Antiangiogenic therapy--evolving view based on clinical trial results显示文摘 | Jayson GC Hicklin DJ Ellis LM | 2012 | Nat Rev Clin Oncol2012，9，5： | 1 |
| 8 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a muhicentre randomised, double-blind, placebo-controlled study 显示文摘 | NAUCK MA ELLIS GC | 2009 | lnt J Clin Prac2009，63，1： | 1 |
| 9 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy:a multicentre,randomised,double-blind,placebo-controlled study显示文摘 | Nauck MA Ellis GC Fleck PR | 2009 | Int J Clin Pract2009，63，： | 1 |
| 10 | Efficacy and safety of adding the dipeptidyl peptidase-d inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metfomin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study显示文摘 | Nauck MA Ellis GC Fleck PR | 2009 | Int J Clin Pract2009，63，1： | 1 |
| 11 | Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone:a 52-week,randomized,double-blind,active-controlled,parallel-group study显示文摘 | Bosi E Ellis GC Wilson CA | 2011 | Diabetes Obes Metab2011，13，： | 1 |
| 12 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study显示文摘 | Nauck MA Ellis GC Fleck PR | 2009 | Int J Clin Pract2009，63，1： | 1 |
| 13 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to matformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo- controlled study显示文摘 | Nauck MA Ellis GC Fleck PR | 2009 | Int J Clin Pract2009，63，1： | 1 |
| 14 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a muhicentre randomised, double-blind, placebo-controlled study 显示文摘 | NAUCK MA ELLIS GC | 2009 | lnt J Clin Prac2009，63，1： | 1 |
| 15 | Efficacy and safety of adding the dipeptidylpeptidase-4 inhibitor alogliptin to metformin therapy in patients withtype 2 diabetes inadequately controlled with metformin monotherapy: amulticentre randomised, double-blind, placebo-controlled study显示文摘 | Nauck MA Ellis GC | 2009 | Int JClin Prac2009，63，1： | 1 |
| 16 | Exercise for intermittent claudication显示文摘 | Watson L Ellis B Leng GC | 2008 | Cochrane Database Syst Rev2008，，00： | 1 |
| 17 | Exercise for intermit- tent claudication 显示文摘 | Watson L Ellis B Leng GC | 2008 | Cochrane Database Syst Rev2008，，00： | 1 |
| 18 | Exercise for intermittent claudication显示文摘 | Watson L Ellis B Leng GC | | Cochrane Database Syst0，，： | 1 |
| 19 | Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with met- formin monotherapy : a multicentre, randomised, double-blind, pla- cebo-controlled study显示文摘 | Nauck MA Ellis GC Fleck PR et l | 2009 | Int J Clil Pract2009，63，1： | 1 |
| 20 | Fever and pulmonary thrombolism显示文摘 | Murray HW Ellis GC Blumenthal | 1979 | Am J Med1979，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员